Fig. 3From: Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in GermanyPrevalence of SABA overuse in patients treated in general and pneumologist practices in Germany. GINA Global Initiative for Asthma, GP general practitioner, ICS inhaled corticosteroid, LABA long-acting beta agonist, SABA short-acting beta-2 agonistBack to article page